About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5630 record(s)
Req # A-2024-000143
Any internal communications in the Controlled Substances and Cannabis Branch (CSCB) and any communications received by the CSCB suggesting that "CLTS" as an acronym for the "cannabis licensing and tracking system" might not be…Organization: Health Canada
June 2024
Req # A-2024-000158
For each communication number referenced below, provide all material associated with the meetings or activities identified in the Registry of Lobbyists for Moderna 370107-514439, 370107-516631, 370107-516634, 370107-521451.Organization: Health Canada
June 2024
Req # A-2021-001060
Adverse Drug Reaction (ADR) for HYOSCINE BUTYLBROMIDE. Report number: 000940500.Organization: Health Canada
June 2024
Req # A-2023-000466
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-103001-532.Organization: Health Canada
June 2024
Req # A-2023-000822
Adverse Drug Reactions (ADRs). Report numbers: 000660910, 000661151, 000681049, 000677875, 000681066, 000635689, E2B_00410673, 000654664, 000653870.Organization: Health Canada
June 2024
Req # A-2023-000927
Adverse Drug Reactions (ADRs). Report numbers: 001000619, 001000617, 001016116, 001023612, 001016246, E2B_03420909, 001024306, E2B_03420926, E2B_03425375, E2B_04095452.Organization: Health Canada
June 2024
Req # A-2023-000960
Adverse Drug Reactions (ADRs). Report numbers: E2B_05717142, 000958431, E2B_05884138, E2B_04805091, E2B_05237961, E2B_02682225, E2B_06313611, E2B_06254622, E2B_06254676, E2B_06304193.Organization: Health Canada
June 2024
Req # A-2023-001200
Adverse Drug Reactions (ADRs) for Aripiprazole. Report numbers: 001062050, 001064762, 001064827, 001065900, 001066524, 001067120, 001067530, E2B_06602631, E2B_06612964, E2B_06624149.Organization: Health Canada
June 2024
Req # A-2023-001259
Adverse Drug Reactions (ADRs). Report numbers: E2B_04370904, E2B_06667368, E2B_06549930, E2B_06689043.Organization: Health Canada
June 2024
Req # A-2023-001262
Adverse Drug Reaction (ADR). Report number: E2B_0675480.Organization: Health Canada
June 2024